--2024/Q4-- / 2.800M--
--2023/Q3338.000K / 700.000K--
--2023/Q2937.000K / 750.000K--
--2023/Q11.286M / 700.000K--
--2022/Q459.000K / 1.555M--
Strategy
MSTR
Meta Platforms
META
Oracle
ORCL
Amazon
AMZN
Salesforce
CRM
US Stock MarketDetailed Quotes
SNTI Senti Biosciences
- 3.8400
- +0.0700+1.86%
Close Feb 26 16:00 ET
- 3.8400
- 0.00000.00%
Post 20:01 ET
17.62MMarket Cap-0.25P/E (TTM)
3.9000High3.8200Low6.77KVolume3.8900Open3.7700Pre Close26.15KTurnover0.26%Turnover RatioLossP/E (Static)4.59MShares16.940052wk High1.10P/B9.87MFloat Cap1.520152wk Low--Dividend TTM2.57MShs Float105.4000Historical High--Div YieldTTM2.12%Amplitude1.5200Historical Low3.8630Avg Price1Lot Size
Senti Biosciences Key Stats
Senti Biosciences Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Senti Biosciences Earnings Reports
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data